Page 12 - My FlipBook

INDEX

AI (artificial intelligence), 41 stem cells. (see stem cells) genetic engineering, 45, 67
channelrhodopsin-2 (CR-2),
biobots, 4, 6, 58 54–55, 57, 59 infographics, 24
biological intelligence, 41 chemogenetics, 63–64. brain, 64
ethics of, 42 (see also optogenetics) DNA, 13, 45
biomedical engineering, 4, conditions and diseases gene editing, 46
35–38 cancer. (see cancer) retina, 56
advancements, 23 diabetes, 67 iPS cells (induced pluripotent
applications, 6 epilepsy, 33, 64 stem cells), 25, 30–31
careers in, 74–81 hemophilia, 53 as alternative to stem
blindness, 14 Hunter’s syndrome, 53 cells, 12–13
artificial retinas, 5 lung disease, 25
channelrhodopsin-2 (CR -2), Parkinson’s disease, 62 JCVI-syn3.0, 68–69
54–55, 57 quadriplegia, 35–36 magnetogenetics, 63.
and optogenics, 54–56 sickle cell disease, 47, See also optogenetics
brain-computer interface 53, 76 microbiota, 6, 65–66, 70–73
(BCI) technology, 5, spina bifida, 18–21 Bacteroides, 70–71
32–33, 35, 38–42, 77 urea cycle disorder, 68–69 and pharmaceutical drugs,
BCI-VR, 36–37 CRISPR-Cas9, 46–48 67
brain to brain, 34, 43 and bacteria, 46–47 probiotics, 66–67
cost of, 37 clinical trials, 47 redesigned bacteria,
ethics of, 40–41 lab studies, 49–53 67–70
brain implants, 36–39, 62, 78 risks, 50–51 synthetic bacteria, 67–69,
electroencephalograph 72–73
(EEG), 33–35, 39, 43 de-extinction, 48
history of, 35 DNA (deoxyribonucleic acid), neuroengineering, 5
and spinal cord injuries, 35 13, 48, 57, 61, 67–68, ethics of, 40–41
brain-to-brain, 34 73 Nobel Prize, 12
copying, 47, 67, 69
cancer, 6, 15, 19, 27–28 cutting, 44–45, 53 opsin, 57–59, 61, 63
CAR-T cell therapy, 52 editing, 46–47, 49–53 optogenetics, 54–55, 63
chemotherapy, 22, 52, 73 insertion, 44–45, 53, 59 blindness, 54–57
gene editing, 45, 49–51 sequences, 53, 67–68, 78 hearing loss, 62–63
radiation, 22, 52–53 drug development protocol, memory, 54, 58–59
synthetic bacteria, 70, 28–29 pain management, 54,
72–73 59–62
careers, 74–81 ethics and bioengineering, organs, 18–31, 65
cells, 4–6, 13, 16, 19–21, 12, 40–42 lab-grown organs, 4,
23–26, 28, 45–46, gene-edited babies 19–21, 48
52–57, 60, 63–65, scandal, 50–51 on-a-chip, 4, 27–31
67–70, 73, 79–80 gene editing, 49, 72 regeneration, 4, 7–9,
blood cells, 9–13, 17, extracellular matrix (ECM), 15–16
47–49, 65–66 23–24 repair, 4
egg cells, 9–10, 22 3D-printed, 19
muscle cells, 9, 11–12, gene therapy, 45–46, 52–54, transplants, 19–20, 25, 48
20, 58 62, 80 transplant shortage, 20,
skin cells, 9–12, 21–23 application, 51, 57, 59 26, 48

93